Torray Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Torray Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-161,134	Closed	-$11.2M	–	99
2023 Q1	$11.2M	Hold	161,134	–	–	2%	20
2022 Q4	$11.6M	Hold	161,134	–	–	2.09%	15
2022 Q3	$11.5M	Sell	161,134 -26,406	-14%	-$1.92M	2.28%	12
2022 Q2	$14.4M	Sell	187,540 -29,231	-13%	-$2.23M	2.76%	6
2022 Q1	$15.8M	Sell	216,771 -281	-0.1%	-$18.9K	2.54%	8
2021 Q4	$13.5M	Buy	217,052 +2,456	+1%	+$144K	2%	19
2021 Q3	$12.7M	Hold	214,596	–	–	1.94%	19
2021 Q2	$14.3M	Hold	214,596	–	–	2.11%	18
2021 Q1	$13.5M	Buy	214,596 +49,956	+30%	+$3.11M	2.12%	22
2020 Q4	$10.2M	Buy	164,640 +63	+0%	+$3.87K	1.68%	24
2020 Q3	$9.92M	Sell	164,577 -3,017	-2%	-$182K	1.82%	23
2020 Q2	$9.86M	Sell	167,594 -181	-0.1%	-$10.8K	1.86%	21
2020 Q1	$9.35M	Buy	+167,775	New	+$10.3M	2.07%	19
2015 Q3	–	Sell	-3,222	Closed	-$214K	–	64
2015 Q2	$214K	Hold	3,222	–	–	0.01%	64
2015 Q1	$208K	Buy	+3,222	New	+$202K	0.02%	63

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Torray Investment Partners's BMY Position: Q2 2023 in Review

Torray Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 161,134 shares — an estimated $11.2M sold.

Torray Investment Partners first reported a position in BMY in Q1 2015 and held it in 15 quarters. The position peaked at $15.8M in Q1 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Torray Investment Partners reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Torray Investment Partners sold 161,134 Bristol-Myers Squibb shares in Q2 2023, an estimated $11.2M.
Torray Investment Partners first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 15 quarters.
Torray Investment Partners's Bristol-Myers Squibb position peaked at $15.8M in Q1 2022.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Torray Investment Partners's 13F filing for Q2 2023, filed 20 Jul 2023.